CareDx PE ratio CDNA
Share price divided by earnings per share over the last twelve months, since 2025.
- Today, Oct 23, 2026
- 33.4×
- Peer median
- 42.0×
CareDx's PE ratio is 33.4× as of Oct 23, 2026: a share price of $69.21 against $2.07 of earnings per share over the last twelve months.
The median for 10 diagnostics and research stocks of a similar size is 42.0×.
PE ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 33.4× | 16.8× | 33.4× |
| 2025 | 19.1× | 12.2× | 26.1× |
Against its peers
Companies in Medical - Diagnostics & Research nearest CareDx's size, closest first, today.
| Company | PE ratio |
|---|---|
| CDNACareDx | 33.4× |
| VCYTVeracyte | 34.2× |
| BLLNBillionToOne | 166× |
| LNTHLantheus | 24.2× |
| CAICaris Life Sciences | 86.5× |
| BIOBio-Rad Laboratories | 44.8× |
| RVTYRevvity | 75.6× |
| MEDPMedpace | 39.2× |
| NRCNRC Health | 87.7× |
| LHLabcorp | 27.2× |
| DGXQuest Diagnostics | 25.7× |
| Peer median | 42.0× |
Where CareDx ranks
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on CareDx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.